Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection, McHutchison et al. (2009).
Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients, Qiu et al. (2011).
Carrat et al. (2004). Study to evaluate the safety and efficacy of peginterferon
alfa-
Management and Treatment of Hep C viral Infection: recommendations from the Department of Veterans Affairs Hepatitis C resource Center program and national Hepatitis C Program Office
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection, Hezode et al. (2009).
Bacon et al. (2011). Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection,
The New England Journal of Medicine, 364 (13), 1207-
Poordad et al. (2011). Boceprevir for Untreated Chronic HCV Genotype 1 Infection.
The New England Journal of Medicine, 364 (13), 1195-
Lok et al. (2012). Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype
1. The New England Journal of Medicine, 366, 216-
Jacobson et al. (2011). Telaprevir for Previously Untreated Chronic Hepatitis C Virus
Infection. The New England Journal of Medicine. 364: 2405-
Kwo et al. (2010). Efficacy of boceprevir, an NS3 protease inhibitor, in combination
with peginterferon alfa-